default author photo

Jundong Li

Sun Yat-sen University (SYSU)

SCHOLARLY PAPERS

2

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Molecular Signatures and Clinical Significance of Homologous Recombination Deficiency in Endometrial Cancer

Number of pages: 18 Posted: 28 Aug 2023
Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Beijing Genomics Institute (BGI), Beijing Genomics Institute (BGI), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Beijing Genomics Institute (BGI), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy and Sun Yat-sen University (SYSU)
Downloads 93 (725,554)

Abstract:

Loading...

homologous repair deficiency, homologous recombination repair, large-scale state transition loss, endometrial cancer, mutational signature, prognosis

2.

Neoadjuvant Niraparib Monotherapy for Newly Diagnosed Unresectable HRD-Positive High-Grade Serous Ovarian Cancer (NANT): A Multicenter, Prospective, Phase 2 Trial

Number of pages: 31 Posted: 09 Feb 2026
Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Sichuan University, Sun Yat-sen University (SYSU), Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology - Department of Radiology, Huazhong University of Science and Technology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Shandong University, Wuhan University, Sichuan University, Sichuan University, Sichuan University, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, University of California, San Francisco (UCSF), Zai Lab (Shanghai) Co, Ltd., Precision Scientific (Beijing) Co., Ltd., Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Guangdong Academy of Medical Sciences, Huazhong University of Science and Technology - Hubei Cancer Hospital, Independent, Shandong University, Wuhan University - Department of Gynecology and Obstetrics, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology and Huazhong University of Science and Technology - Cancer Biology Research Center
Downloads 37 (1,263,436)

Abstract:

Loading...

Ovarian cancer, neoadjuvant therapy, PARP inhibitor, homologous recombination deficiency